Brochures

1. Powering Possibilities In Early Phase Development 7/21/2026

   Streamline early biologics development by combining model-guided sequence selection with parallel scale-up strategies to overcome cell line unpredictability and reduce tech transfer risks.

2. Early Stage Capability From Sequence To IND And Beyond 6/11/2026

   See early-stage CDMO capabilities at a specialized bio campus, detailing process development, analytical support, bioconjugation services, cell banking, and scalable manufacturing solutions.

3. Songdo Bio Campus Plant 1 6/11/2026

   Learn about a cGMP-ready plant featuring a multi-floor gravity flow design, substantial bioreactor capacity, and dual-site operations to support scalable commercial biopharmaceutical manufacturing.

4. Syracuse Bio Campus: Every Detail. Built Around You 4/17/2026

   The Syracuse Bio Campus offers U.S.-based mammalian production and bioconjugation, supporting development through commercial manufacturing with regulatory expertise and tailored solutions.

5. Your U.S.- Based Bioconjugation Partner 4/13/2026

   Single‑site ADC manufacturing integrates antibody production, conjugation, and quality systems to reduce complexity, accelerate timelines, and support scalable clinical‑to‑commercial development.

6. Songdo Bio Campus: Advanced Manufacturing, Coming Summer 2026 2/3/2026

   A new biomanufacturing campus in Incheon features automation, digital monitoring, flexible large-scale production, and 120kL capacity, with completion expected in 2026.

7. Tailored CDMO Solutions With Unmatched Quality 1/14/2026

   Partner with a premier global CDMO to move from discovery to commercialization faster, powered by dual-site manufacturing, 20+ years of expertise, and advanced ADC conjugation.